SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The December 2022 quarter revenue stood at Rs. 13264.80 millions, up 8.34% as compared to Rs. 12243.60 millions during the corresponding quarter last year.A slim rise of 23.91% was recorded in the Net profit for the quarter ended December 2022 to Rs. 2468.30  millions  From Rs. 1992.00 millions.Operating Profit saw a handsome growth to 3564.30 millions from 2878.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 13264.80 12243.60 8.34 40103.30 36642.50 9.44 49192.70 43100.20 14.14
Other Income 399.40 187.40 113.13 998.30 561.60 77.76 772.10 809.00 -4.56
PBIDT 3564.30 2878.00 23.85 10300.20 8500.60 21.17 11649.30 10023.60 16.22
Interest 37.90 44.10 -14.06 119.80 139.60 -14.18 191.00 182.80 4.49
PBDT 3526.40 2833.90 24.44 10180.40 8361.00 21.76 11458.30 9840.80 16.44
Depreciation 178.10 167.40 6.39 526.30 486.70 8.14 661.00 581.30 13.71
PBT 3348.30 2666.50 25.57 9654.10 7874.30 22.60 10797.30 9259.50 16.61
TAX 880.00 674.50 30.47 2474.20 2001.40 23.62 2810.30 2352.60 19.46
Deferred Tax -16.80 -6.10 175.41 -47.30 -75.50 -37.35 41.80 -37.90 -210.29
PAT 2468.30 1992.00 23.91 7179.90 5872.90 22.25 7987.00 6906.90 15.64
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 26.87 23.51 14.31 25.68 23.20 10.71 23.68 23.26 1.82

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×